company background image
ALKEM logo

Alkem Laboratories NSEI:ALKEM Stock Report

Last Price

₹4.85k

Market Cap

₹579.6b

7D

-0.3%

1Y

-5.0%

Updated

15 Jun, 2025

Data

Company Financials +

Alkem Laboratories Limited

NSEI:ALKEM Stock Report

Market Cap: ₹579.6b

Alkem Laboratories (ALKEM) Stock Overview

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. More details

ALKEM fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

ALKEM Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Alkem Laboratories Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Alkem Laboratories
Historical stock prices
Current Share Price₹4,847.50
52 Week High₹6,439.90
52 Week Low₹4,491.65
Beta0.42
1 Month Change-7.15%
3 Month Change0.61%
1 Year Change-4.99%
3 Year Change56.45%
5 Year Change110.27%
Change since IPO250.84%

Recent News & Updates

Alkem Laboratories (NSE:ALKEM) Is Due To Pay A Dividend Of ₹8.00

Jun 02
Alkem Laboratories (NSE:ALKEM) Is Due To Pay A Dividend Of ₹8.00

Getting In Cheap On Alkem Laboratories Limited (NSE:ALKEM) Is Unlikely

May 19
Getting In Cheap On Alkem Laboratories Limited (NSE:ALKEM) Is Unlikely

Recent updates

Alkem Laboratories (NSE:ALKEM) Is Due To Pay A Dividend Of ₹8.00

Jun 02
Alkem Laboratories (NSE:ALKEM) Is Due To Pay A Dividend Of ₹8.00

Getting In Cheap On Alkem Laboratories Limited (NSE:ALKEM) Is Unlikely

May 19
Getting In Cheap On Alkem Laboratories Limited (NSE:ALKEM) Is Unlikely

Here's Why We Think Alkem Laboratories (NSE:ALKEM) Is Well Worth Watching

Mar 26
Here's Why We Think Alkem Laboratories (NSE:ALKEM) Is Well Worth Watching

₹5,396: That's What Analysts Think Alkem Laboratories Limited (NSE:ALKEM) Is Worth After Its Latest Results

Feb 12
₹5,396: That's What Analysts Think Alkem Laboratories Limited (NSE:ALKEM) Is Worth After Its Latest Results

Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Increased To ₹37.00

Feb 11
Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Increased To ₹37.00

Alkem Laboratories Limited's (NSE:ALKEM) Shares May Have Run Too Fast Too Soon

Feb 01
Alkem Laboratories Limited's (NSE:ALKEM) Shares May Have Run Too Fast Too Soon

Is Alkem Laboratories (NSE:ALKEM) A Risky Investment?

Jan 10
Is Alkem Laboratories (NSE:ALKEM) A Risky Investment?
author-image

Emerging Market Expansion And Tactical US Product Launches To Fuel Significant Growth

Profitability is improving through high-margin product focus, cost control, and strategic U.S. product launches to counter prior market challenges.

Alkem Laboratories Limited Recorded A 5.4% Miss On Revenue: Analysts Are Revisiting Their Models

Nov 16
Alkem Laboratories Limited Recorded A 5.4% Miss On Revenue: Analysts Are Revisiting Their Models

Here's Why We Think Alkem Laboratories (NSE:ALKEM) Is Well Worth Watching

Nov 15
Here's Why We Think Alkem Laboratories (NSE:ALKEM) Is Well Worth Watching

What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You

Sep 24
What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Sep 03
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 13
Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Jul 13
Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Shareholder Returns

ALKEMIN PharmaceuticalsIN Market
7D-0.3%1.4%-0.9%
1Y-5.0%13.0%-0.3%

Return vs Industry: ALKEM underperformed the Indian Pharmaceuticals industry which returned 13% over the past year.

Return vs Market: ALKEM underperformed the Indian Market which returned -0.3% over the past year.

Price Volatility

Is ALKEM's price volatile compared to industry and market?
ALKEM volatility
ALKEM Average Weekly Movement3.5%
Pharmaceuticals Industry Average Movement6.5%
Market Average Movement6.6%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market4.4%

Stable Share Price: ALKEM has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: ALKEM's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197317,432Vikas Guptawww.alkemlabs.com

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastro-intestinal, pain/analgesic, anti-diabetic, neuro/central nervous system, gynecology, respiratory, dermatology, and cardiac diseases. It also provides vitamins, minerals, and nutrients, as well as mouth wash, shampoos, pregnancy detection kits, and condoms.

Alkem Laboratories Limited Fundamentals Summary

How do Alkem Laboratories's earnings and revenue compare to its market cap?
ALKEM fundamental statistics
Market cap₹579.59b
Earnings (TTM)₹21.65b
Revenue (TTM)₹129.65b
26.8x
P/E Ratio
4.5x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALKEM income statement (TTM)
Revenue₹129.65b
Cost of Revenue₹47.64b
Gross Profit₹82.00b
Other Expenses₹60.35b
Earnings₹21.65b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)181.11
Gross Margin63.25%
Net Profit Margin16.70%
Debt/Equity Ratio8.5%

How did ALKEM perform over the long term?

See historical performance and comparison

Dividends

0.9%
Current Dividend Yield
25%
Payout Ratio

Does ALKEM pay a reliable dividends?

See ALKEM dividend history and benchmarks
When do you need to buy ALKEM by to receive an upcoming dividend?
Alkem Laboratories dividend dates
Ex Dividend DateAug 08 2025
Dividend Pay DateSep 24 2025
Days until Ex dividend53 days
Days until Dividend pay date100 days

Does ALKEM pay a reliable dividends?

See ALKEM dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/15 23:39
End of Day Share Price 2025/06/13 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alkem Laboratories Limited is covered by 35 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nitin BhasinAmbit Capital
Prashant NairAmbit Capital
Shrikant AkolkarAngel Broking Private Limited